Systemic sclerosis (scleroderma) trials in Sweden

In Sweden 8 Also abroad 213

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Study of AZD0120 in Autoimmune Diseases
Where
Huddinge
Age
18 years to 75 years
People
27 worldwide
Run by
AstraZeneca
See details and how to joinNCT07295847
Phase 3Taking people
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Where
Solna
Age
18 years and over
People
448 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00
Phase 1Taking people
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Where
Uppsala
Age
12 years to 70 years
People
244 worldwide
Run by
Fate Therapeutics
See details and how to joinNCT06308978
Phase 1Not yet taking people in Sweden
Exploratory, non-randomized, 3-group, microdosing clinical trial to investigate Gallium-68 (68Ga) labeled Platelet-Derived Growth Factor Beta (PDGFRß) targeting Positron Emission Tomography (PET) tracer (68Ga-ATH001) binding in the lungs in healthy participants versus participants with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)
Where
Uppsala
Age
18 years and over
People
15
Run by
Antaros Medical AB
See details and how to join2026-525309-11-00 · EU 2026-525309-11-00
No phaseTaking people
EFESO: Study on Juvenile Onset Eosinophilic Fasciitis
Where
Solna
Age
Up to 18 years
People
20 worldwide
Run by
Meyer Children's Hospital IRCCS
See details and how to joinNCT07348263
No phaseTaking people
Western Sweden Systemic Sclerosis Project
Where
Gothenburg
Age
18 years and over
People
150
Run by
Sahlgrenska University Hospital
See details and how to joinNCT07345052
Phase 4Enrolling by invitation
Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
Where
Lund
Age
18 years and over
People
240
Run by
Region Skane
See details and how to joinNCT06763783
Phase 4Taking people
Vaccination in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on the immunogenicity of herpes-zoster vaccine (Shingrix) and protection against infection (HZ-REUMA)
Where
Lund
Age
18 years and over
People
1
Run by
Region Skane Skanes Universitetssjukhus
See details and how to join2023-506230-71-01 · EU 2023-506230-71-01